{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T18:07:01Z","timestamp":1776881221775,"version":"3.51.2"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007225","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["MOST:103-2314-B-037-033"],"award-info":[{"award-number":["MOST:103-2314-B-037-033"]}],"id":[{"id":"10.13039\/100007225","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007225","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["MOST:104-2314-B-037-054"],"award-info":[{"award-number":["MOST:104-2314-B-037-054"]}],"id":[{"id":"10.13039\/100007225","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011645","name":"Kaohsiung Medical University Chung-Ho Memorial Hospital","doi-asserted-by":"publisher","award":["KMUH:103-3R10"],"award-info":[{"award-number":["KMUH:103-3R10"]}],"id":[{"id":"10.13039\/501100011645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011645","name":"Kaohsiung Medical University Chung-Ho Memorial Hospital","doi-asserted-by":"publisher","award":["KMUH:104-4R11"],"award-info":[{"award-number":["KMUH:104-4R11"]}],"id":[{"id":"10.13039\/501100011645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011645","name":"Kaohsiung Medical University Chung-Ho Memorial Hospital","doi-asserted-by":"publisher","award":["KMUH104-4M06"],"award-info":[{"award-number":["KMUH104-4M06"]}],"id":[{"id":"10.13039\/501100011645","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Although the bio-incompatibility of glucose-based peritoneal dialysis (PD) solution is well documented, it is used worldwide. How PD duration and the amount of dialyzate glucose exposure affect survival in patients with end-stage renal disease remain inconclusive due to improper study designs in the extant literature.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>All incident patients with PD from 2004 to 2007 who were older than 18 years in Taiwan were included. Patients were censored when they received a transplant or at the end of 2012. Glucose exposure through PD solution was calculated by the mean glucose contained per liter when receiving PD. For those who had already shifted to hemodialysis (HD) and survived longer than 2, 3, and 4 years (the index dates), the cause-specific Cox regression model was used to make the survival comparison by PD duration and mean glucose concentration in these three cohorts, respectively. The model was adjusted by demographics, case-mix, time cohort (2004\u20132005 <jats:italic>vs.<\/jats:italic> 2006\u20132007), peritonitis episode (none <jats:italic>vs<\/jats:italic>. \u2265once), and mean PD solution glucose exposure (tertile).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 3,226 patients were included, with a mean age of 53.4 \u00b1 15.2 years, 44.6% being male, and 34.2% having diabetes mellitus. The 1, 2, 3, and 4-year survival rates were 94, 87, 80, and 74%, while technical survival rates were 86, 70, 56, and 45%, respectively. The overall transplant events were 309 (9.6%) only. There were 389, 495, and 553 incident patients with PD shifting to HD included in 2-, 3-, and 4-year cohort, respectively. The population with moderate glucose concentration exposure had the highest mortality, and the high glucose concentration exposure had non-significant lower mortality in each cohort. In various fixed time-window cohorts, the duration of PD treatment did not increase mortality risk after adjustments. In addition, glucose exposure did not affect the mortality rate.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>For incident PD patients with PD duration no longer than 4 years, neither PD duration nor glucose exposure amount increases the long-term mortality risk.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.897545","type":"journal-article","created":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T05:02:06Z","timestamp":1656392526000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Dialysis Duration and Glucose Exposure Amount Do Not Increase Mortality Risk in Peritoneal Dialysis Patients: A Population-Based Cohort Study From 2004 to 2012"],"prefix":"10.3389","volume":"9","author":[{"given":"Pei-Yu","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Yen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shang-Jyh","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Wen","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1093\/ndt\/gfp054","article-title":"Benefits of biocompatible Pd fluid for preservation of residual renal function in incident Capd patients: a 1-year study.","volume":"24","author":"Kim","year":"2009","journal-title":"Nephrol Dial Transplant."},{"key":"B2","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3747\/pdi.2010.00176","article-title":"A study of the clinical and biochemical profile of peritoneal dialysis fluid low in glucose degradation products.","volume":"32","author":"Lai","year":"2012","journal-title":"Perit Dial Int."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1093\/ndt\/gft050","article-title":"Impact of icodextrin on clinical outcomes in peritoneal dialysis: a systematic review of randomized controlled trials.","volume":"28","author":"Cho","year":"2013","journal-title":"Nephrol Dial Transplant."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e0141425","DOI":"10.1371\/journal.pone.0141425","article-title":"The effect of neutral peritoneal dialysis solution with low glucose-degradation-product on the fluid status and body composition\u2013a randomized control trial.","volume":"10","author":"Szeto","year":"2015","journal-title":"PLoS One."},{"key":"B5","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1681\/ASN.V11111969","article-title":"Effect of glucose on intercellular junctions of cultured human peritoneal mesothelial cells.","volume":"11","author":"Ito","year":"2000","journal-title":"J Am Soc Nephrol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1053\/ajkd.1998.v31.pm9469498","article-title":"Effect of glucose concentration, osmolality, and sterilization process of peritoneal dialysis fluids on cytokine production by peripheral blood mononuclear cells and polymorphonuclear cell functions in vitro.","volume":"31","author":"Cendoroglo","year":"1998","journal-title":"Am J Kidney Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1681\/ASN.V114729","article-title":"Effect of glucose degradation products on human peritoneal mesothelial cell function.","volume":"11","author":"Witowski","year":"2000","journal-title":"J Am Soc Nephrol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1046\/j.1523-1755.2002.00115.x","article-title":"Ages bind to mesothelial cells via rage and stimulate Vcam-1 expression.","volume":"61","author":"Boulanger","year":"2002","journal-title":"Kidney Int."},{"key":"B9","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1053\/ajkd.2003.50087","article-title":"Role of advanced glycation end products and growth factors in peritoneal dysfunction in capd patients.","volume":"41","author":"Nakamura","year":"2003","journal-title":"Am J Kidney Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1681\/ASN.V1251046","article-title":"Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis.","volume":"12","author":"Davies","year":"2001","journal-title":"J Am Soc Nephrol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3747\/pdi.2013.00075","article-title":"Predictors of residual renal function decline in patients undergoing continuous ambulatory peritoneal dialysis.","volume":"35","author":"Szeto","year":"2015","journal-title":"Perit Dial Int."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e30337","DOI":"10.1371\/journal.pone.0030337","article-title":"Safety issues of long-term glucose load in patients on peritoneal dialysis\u2013a 7-year cohort study.","volume":"7","author":"Wu","year":"2012","journal-title":"PLoS One."},{"key":"B13","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/ki.1997.22","article-title":"Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in Capd.","volume":"51","author":"Nakayama","year":"1997","journal-title":"Kidney Int."},{"key":"B14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s10047-013-0741-1","article-title":"Accumulation of advanced glycation end products and beta 2-microglobulin in fibrotic thickening of the peritoneum in long-term peritoneal dialysis patients.","volume":"17","author":"Nakamoto","year":"2014","journal-title":"J Artif Organs."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.2215\/CJN.01260209","article-title":"Encapsulating peritoneal sclerosis in the new millennium: a national cohort study.","volume":"4","author":"Brown","year":"2009","journal-title":"Clin J Am Soc Nephrol."},{"key":"B16","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0272-6386(04)00953-9","article-title":"Encapsulating peritoneal sclerosis in japan: a prospective, controlled, multicenter study.","volume":"44","author":"Kawanishi","year":"2004","journal-title":"Am J Kidney Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3747\/pdi.2017.00018","article-title":"Length of time on peritoneal dialysis and encapsulating peritoneal sclerosis - position paper for ispd: 2017 update.","volume":"37","author":"Brown","year":"2017","journal-title":"Perit Dial Int."},{"key":"B18","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1159\/000128608","article-title":"Initial glucose load predicts technique survival in patients on chronic peritoneal dialysis.","volume":"28","author":"Wu","year":"2008","journal-title":"Am J Nephrol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3747\/pdi.2013.00083","article-title":"High glucose concentrations in peritoneal dialysate are associated with all-cause and cardiovascular disease mortality in continuous ambulatory peritoneal dialysis patients.","volume":"35","author":"Wen","year":"2015","journal-title":"Perit Dial Int."},{"key":"B20","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3389\/fphys.2019.00150","article-title":"Impact of glucose exposure on outcomes of a nation-wide peritoneal dialysis cohort - results of the Brazpd Ii cohort.","volume":"10","author":"Radunz","year":"2019","journal-title":"Front Physiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.1038\/s41598-019-40692-6","article-title":"Predictors of outcomes in patients on peritoneal dialysis: a 2-year nationwide cohort study.","volume":"9","author":"Abe","year":"2019","journal-title":"Sci Rep."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e0196294","DOI":"10.1371\/journal.pone.0196294","article-title":"Survival predictors in anuric patients on peritoneal dialysis: a prospective, multicenter, propensity score-matched cohort study.","volume":"13","author":"Park","year":"2018","journal-title":"PLoS One."},{"key":"B23","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2147\/CLEP.S196293","article-title":"Taiwan\u2019s national health insurance research database: past and future.","volume":"11","author":"Hsieh","year":"2019","journal-title":"Clin Epidemiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with Icd-9-Cm administrative databases.","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12882-020-01822-9","article-title":"Abdominal aortic calcification score as a predictor of clinical outcome in peritoneal dialysis patients: a prospective cohort study.","volume":"21","author":"Ma","year":"2020","journal-title":"BMC Nephrol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1159\/000381663","article-title":"High peritoneal glucose exposure is associated with increased incidence of relapsing and recurrent bacterial peritonitis in patients undergoing peritoneal dialysis.","volume":"40","author":"Jiang","year":"2015","journal-title":"Blood Purif."},{"key":"B27","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1681\/ASN.V132470","article-title":"Morphologic changes in the peritoneal membrane of patients with renal disease.","volume":"13","author":"Williams","year":"2002","journal-title":"J Am Soc Nephrol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/sdi.12870","article-title":"Multicenter laparoscopic evaluation of the peritoneum in peritoneal dialysis patients.","volume":"33","author":"Hara","year":"2020","journal-title":"Semin Dial."},{"key":"B29","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1177\/089686080802805S06","article-title":"Characterization of epithelial-to-mesenchymal transition of mesothelial cells in a mouse model of chronic peritoneal exposure to high glucose dialysate.","volume":"28","author":"Aroeira","year":"2008","journal-title":"Perit Dial Int."},{"key":"B30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.atherosclerosis.2012.06.022","article-title":"Accumulation of tissue advanced glycation end products correlated with glucose exposure dose and associated with cardiovascular morbidity in patients on peritoneal dialysis.","volume":"224","author":"Jiang","year":"2012","journal-title":"Atherosclerosis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3389\/fphys.2019.00356","article-title":"Peritoneal dialysis vintage and glucose exposure but not peritonitis episodes drive peritoneal membrane transformation during the first years of Pd.","volume":"10","author":"Bartosova","year":"2019","journal-title":"Front Physiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1080\/0886022X.2021.1918558","article-title":"Risk factors for mortality in patients undergoing peritoneal dialysis: a systematic review and meta-analysis.","volume":"43","author":"Zhang","year":"2021","journal-title":"Ren Fail."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e0155564","DOI":"10.1371\/journal.pone.0155564","article-title":"Peritoneal dialysate glucose load and systemic glucose metabolism in non-diabetics: results from the global fluid cohort study.","volume":"11","author":"Lambie","year":"2016","journal-title":"PLoS One."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.897545\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T05:02:12Z","timestamp":1656392532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.897545\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,28]]},"references-count":33,"alternative-id":["10.3389\/fmed.2022.897545"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.897545","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,28]]},"article-number":"897545"}}